In recent years, a growing understanding of myotonic dystrophy type 1 (DM1)—an often fatal, devastating, rare neuromuscular disorder that causes muscle weakness and other life-limiting ...
NEW BRIGHTON, MINN. — Twenty-year-old Giacomo Naylor, 16-year-old Lukas Naylor, 13-year-old Isadora Naylor and Gianna Naylor were all born with myotonic dystrophy — a genetic disorder that ...
An estimated 1 in 8,000 individuals, or 870,000 people worldwide, are affected by Facioscapulohumeral muscular dystrophy ...
Investor's Business Daily on MSN2mon
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats UpMuscles in the face, shoulders, arms and legs begin to ... Avidity Biosciences is also testing treatments for myotonic ...
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Myotonic Dystrophy - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The report delivers an in-depth ...
Patients with myotonic dystrophy have smaller hearts, and lower systolic and diastolic blood pressures and pulse rates. They have impaired autonomic reflexes, measured by orthostatic, Valsalva ...
Dyne Therapeutics (NASDAQ:DYN) reported clinical data from its ongoing Phase 1/2 trial of DYNE-101 in patients with myotonic dystrophy type 1. Shares down about 22% in early trade. DYNE-101 continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback